Cita APA

A, C., A, A., C, G., P, E., F, L., JL, M., . . . E, A. (2017). First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).

Citación estilo Chicago

A, Carrato, et al. First-line Panitumumab Plus FOLFOX4 or FOLFIRI in Colorectal Cancer With Multiple or Unresectable Liver Metastases: A Randomised, Phase II Trial (PLANET-TTD). 2017.

Cita MLA

A, Carrato, et al. First-line Panitumumab Plus FOLFOX4 or FOLFIRI in Colorectal Cancer With Multiple or Unresectable Liver Metastases: A Randomised, Phase II Trial (PLANET-TTD). 2017.